| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Commercial Officer
1 company
Tracie Oliver last filed a Form 4 in July 2024, as Chief Commercial Officer at ARWR. Tracie Oliver's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
Our model assigns Tracie Oliver a strong insider score of 70/100, based on 3 past trades. Over a 12-month horizon, all 3 of those trades were profitable, with an average 12-month return of +35.3%.
At the last filing, the largest reported position was 127,107 shares of ARWR. The ARWR filings lean toward selling, a net 18,393 shares.
Tracie Oliver has 4 Form 4 filings on record from January 2023 to July 2024, all as Chief Commercial Officer at Arrowhead Pharmaceuticals (ARWR), 2023–2024.
The 5 reported transactions were 3 open-market sales and 2 stock awards.
Counted by filing, the open-market trades come to no purchases and 3 sales worth about $555K.
The largest open-market sale was 8,925 shares of ARWR at an average $35.31 on July 3, 2023, about $315K. Twelve months later ARWR was down 28%.
2 of the 3 sales since April 2023 were made under a Rule 10b5-1 trading plan; the other was not.
Shares as reported in the last Form 4 for each company; the most recent is from July 2024. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 2, 2024 | ARWR Arrowhead Pharmaceuticals, Inc. | Chief Commercial Officer | Sell10b5-1 | 9,394 | $25.28 | $237,480.32 | -6.9% | -23.2% | -33.0% | |
| Jan 5, 2024 | ARWR Arrowhead Pharmaceuticals, Inc. | Chief Commercial Officer | Sell10b5-1 | 74 | $33.89 | $2,507.86 | - | -26.7% | -44.4% | |
| Jul 3, 2023 | ARWR Arrowhead Pharmaceuticals, Inc. | Chief Commercial Officer | Sell | 8,925 | $35.31 | $315,141.75 | -12.7% | -25.4% | -28.4% |